News
- August 13, 2013
-
May 23, 2013
Leading US and European Medical Public-Private Partnerships Announce Agreement
The Predictive Safety Testing Consortium (PSTC) led by the Critical Path Institute (C-Path) and the Safer and Faster Evidence-based Translation (SAFE-T) consortium sponsored by the Innovative Medicines Initiative (IMI), announced today the signature of an agreement to work together in their efforts to improve drug safety. -
February 21, 2013
Critical Path Institute Names Martha Brumfield CEO
The Board of Directors of the Critical Path Institute (C-Path) announced today that Martha Brumfield, Ph.D., has been named interim president and chief executive officer of the organization. Brumfield, C-Path’s former director of International & Regulatory Programs, takes over immediately for Carolyn Compton, M.D., Ph.D., who will be assuming a new position at Arizona State... -
November 29, 2012
C-Path Cosponsors Workshop on Combination Drug Development for Alzheimer’s Disease
Combination therapy development has been successful in other life-threatening diseases in part because collaborative approaches were established to identify necessary pathways and tools that enabled more efficient trials. The primary goal of this meeting held in Baltimore, MD November 29th 2012 was to explore how similar partnerships could foster more robust collaboration in Alzheimer’s disease... -
November 1, 2012
Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Accelerations Network
Dr Carolyn Compton served as planning committee co-chair for the recent Institute of Medicine workshop, “Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Accelerations Network” on Nov 16.